Latest SciBase News & Updates

See the latest news and media coverage for SciBase. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
SciBase

Medical technology company for dermatological diagnostics

scibase.com
Headquarters
Sundbyberg, Sweden
Founded year
1998
Company type
Public company
Number of employees
50–200

Latest news about SciBase

Company announcements

  • SciBase

    SciBase publishes its 2025 annual report

    A PDF version is enclosed; printed copies available on request. Contact CFO Michael Colérus for more information.

  • SciBase

    SciBase issues notice to attend AGM

    The meeting is on or after May 8, 2026. Proposals include board elections, reverse share split, stock option program, and issuance authorization.

  • SciBase

    SciBase reaches milestone of over 400,000 Nevisense tests sold

    Nevisense, an FDA-approved non-invasive diagnostic for skin cancer, shows promise in atopic dermatitis prediction. CEO Pia Renaudin highlights improved patient outcomes.

  • SciBase

    SciBase releases Q4 and full-year 2025 interim report

    Net sales rose 45% in Q4 and 36% for the year. Electrode sales increased significantly. Rights issue raised SEK 80m.

Unlock all announcements with a

Media coverage

  • Lezard

    Notice to attend the annual general meeting in Scibase Holding AB (publ)

    Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to the annual general meeting to be held on 19 May...

  • Yahoo Finance

    SciBase reaches milestone with over 400,000 tests sold with Nevisense

    SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced a significant milestone with over 400,000 Nevisense...

  • Dagens industri

    Higher turnover but larger loss for Scibase

    The medical technology company Scibase reports an operating result of -26.7 million kronor (-23.6) for the fourth quarter of 2025.

  • Yahoo Finance

    SciBase receives approval by FDA for extended labelling in the US

    SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received approval by FDA...

Unlock all articles with a

Never miss news about SciBase

Track SciBase and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.